2024 SOHN Conference Stock Pitches

Michael Buckley, Duquesne Family Office

Investment idea: Natera (NTRA)

Natera, a medical diagnostics company, could have huge upside based on the strength of its oncology business, according to Michael Buckley, portfolio manager at Duquesne Family Office. Natera shares are higher by more than 47% this year.

Buckley said the firm’s oncology segment, which he said has the potential to detect cancer earlier in patients than has a CT scan, can drive the company’s revenues going forward. Currently, two-thirds of the company’s revenue comes from its women’s health business, he said. What’s more, he expects that the company will be able to reach profitability sooner than the Street currently anticipates.

“Not only is it an exciting stock with incredible growth potential, but it’s one of the few healthcare companies that can both dramatically improve patient outcomes while lowering total system costs,” he said.